LYN and leukemia: It will be interesting to see if these inhibitors that have relatively few side-effects are useful chemotherapeutic agents for other leukaemias/lymphomas or even solid tumors that are shown to utilize Lyn for maintaining their neoplastic state, or in other diseases that appear to involve Lyn, e.g. autoimmune diseases.